Tag: Rigid CGT Container

CryoCase: Rethink the standard. Replace the bag.

Discover the groundbreaking CellSeal® CryoCase™, the first rigid primary container engineered for closed-system fluid processing in cell and gene therapy (CGT) applications. Launched in November 2024, the CryoCase offers unmatched fracture resistance, transparency for quality inspections, and automation-ready design, addressing the common pitfalls of traditional cryobags and cryovials. With proven performance in freeze-thaw processes and enhanced contamination control, CryoCase is revolutionizing CGT manufacturing workflows. Explore white papers, webinars, and case studies to see how CryoCase can transform your storage solutions. Learn more or request your test sample today!